CDRH’s Shuren Talks MDUFA, Industry’s Premarket Wants, Emerging Technologies, And More In Wide-Ranging Interview

CDRH Director Jeff Shuren in his office
CDRH director Jeff Shuren discussed his 2020 priorities with Medtech Insight at his FDA office in White Oak, MD, on 28 February • Source: Ferdous Al-Faruque

More from Regulation

More from Policy & Regulation